Brazil Mice Model Market (2025-2030)
The Brazil Mice Model Market was valued at $12.33 Million in 2025 and projected to reach to $16.96 Million by 2030, representing a compound annual growth rate of 6.6%. Brazil's mice model market is positioned for moderate but consistent growth as the country strengthens its biomedical research capabilities and pharmaceutical development infrastructure.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Brazil Mice Model Market Trends and Insights
- Brazil's growing investment in biomedical research and pharmaceutical development is driving demand for laboratory mice models, which are essential for preclinical testing and drug discovery.
- The market in Brazil reflects increasing adoption of advanced research methodologies and regulatory compliance requirements in the healthcare sector. The expansion of Brazil's research infrastructure and rising government funding for life sciences initiatives are key contributors to market growth through 2030.
- Brazil's pharmaceutical and biotechnology companies are increasingly utilizing mice models to accelerate product development cycles and meet international quality standards.
- This steady growth trajectory positions Brazil as a significant market within Latin America's broader mice model ecosystem..
Key Market Statistics
- CAGR (2025-2030) 6.6% CAGR
- Market Size, 2025 ~USD 12.33 Million
- Forecast, 2030 ~USD 16.96 Million
- Country Brazil
Brazil Mice Model Market Overview
Market Valuation :
Brazil's mice model market is valued at USD 12.33 million in 2025, with projections to reach USD 16.96 million by 2030, representing steady growth in the Latin American biomedical research sector.
Growth Trajectory :
The Brazilian market is expanding at a CAGR of 6.6% through 2030, driven by increased government funding for biomedical research and pharmaceutical development initiatives across the country.
Research Infrastructure Investment :
Brazil's growing investment in biomedical research facilities and pharmaceutical development centers is creating sustained demand for laboratory mice models essential for preclinical testing and drug discovery applications.
Regulatory & Academic Growth :
Expansion of Brazilian universities and research institutions conducting preclinical studies, combined with stricter regulatory requirements for drug testing, is accelerating adoption of standardized mice models in the region.
Brazil Mice Model Market Dynamics
- Increased government funding, expansion of research institutions, and growing collaboration with international pharmaceutical companies are key drivers supporting market expansion through 2030.
- The market benefits from Brazil's strategic position as a leading Latin American research hub and its commitment to developing domestic drug discovery capabilities. The 6.6% CAGR reflects Brazil's emerging status in preclinical research while lagging behind global growth rates of 10%.
- Future growth will be supported by regulatory harmonization with international standards, increased investment in laboratory facilities, and rising demand from both domestic and multinational pharmaceutical companies conducting research operations in Brazil..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Brazil's mice model market is valued at USD 12.33 million in 2025 with projected growth to USD 16.96 million by 2030.
- Brazil is experiencing a 6.6% CAGR, driven by increased biomedical research investment and pharmaceutical development activities.
- Brazil's regulatory environment and quality standards are accelerating adoption of laboratory mice models in preclinical research.
- Brazil's expanding research infrastructure positions it as a key growth market within the Latin American region.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area, End User |
Brazil Mice Model Market Report Segmentation
6 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
By End User
- Academic & Research Institutes
- Contract Research Organizations (Cros) & Contract Development And Manufacturing Organizations (Cdmos)
- Pharmaceutical & Biotechnology Companies
BRAZIL: MICE MODEL TYPE MARKET, BY END USER, 2023–2030
| Segment | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 3.9 | 4.1 | 4.4 | 4.8 | 5.1 | 5.4 | 5.7 | 5.9 | 5.9 |
| CROS & CDMOS | 1.8 | 1.9 | 2 | 2.2 | 2.4 | 2.5 | 2.6 | 2.8 | 6.5 |
| PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES | 5 | 5.4 | 5.9 | 6.4 | 6.9 | 7.4 | 7.8 | 8.3 | 7.1 |
| TOTAL | 10.7 | 11.4 | 12.3 | 13.4 | 14.3 | 15.3 | 16.1 | 17 | 6.6 |
Target Audience
- Pharmaceutical Companies : Brazilian and multinational pharmaceutical firms establishing or expanding preclinical research operations need market data to assess mice model supplier availability, pricing structures, and regulatory compliance requirements in Brazil.
- Contract Research Organizations (CROs) : CROs operating in Brazil require detailed market intelligence on demand trends, competitor activities, and growth opportunities to optimize service offerings and capture market share in the expanding preclinical testing segment.
- Laboratory Animal Suppliers : Mice breeding facilities and laboratory animal vendors need Brazil-specific market insights to identify growth opportunities, understand customer requirements, and develop distribution strategies for this emerging market.
- Research Institutions & Universities : Brazilian academic and government research institutions need market data to justify funding requests, benchmark their research capabilities, and understand industry trends influencing preclinical research demand.
- Investment & Venture Capital Firms : Investors evaluating biotech and pharmaceutical opportunities in Brazil require market sizing and growth projections to assess investment potential in mice model suppliers, CROs, and related research infrastructure companies.
Key Companies in the Brazil Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Brazil-Specific Market Sizing : Obtain precise valuation data for Brazil's mice model market with verified 2025 baseline (USD 12.33M) and 2030 forecasts, enabling accurate budget allocation and market entry strategies specific to this emerging Latin American market.
- Competitive Landscape Intelligence : Understand Brazil's unique competitive dynamics, local supplier networks, and market consolidation trends that differ significantly from global patterns, providing strategic advantages for market positioning and partnership development.
- Regulatory & Infrastructure Insights : Access detailed analysis of Brazil's regulatory environment, research institution growth, and government funding initiatives driving mice model demand, critical for compliance planning and facility investment decisions.
- Growth Opportunity Identification : Identify high-potential segments within Brazil's 6.6% CAGR growth trajectory, including emerging pharmaceutical hubs, academic research expansion, and multinational R&D centers establishing operations in the region.
- Localized Strategic Planning : Develop Brazil-focused go-to-market strategies informed by regional demand drivers, customer preferences, distribution channels, and investment trends specific to the Brazilian biomedical research ecosystem.
Frequently asked questions
What is the current size of Brazil's mice model market?
Brazil's mice model market is valued at USD 12.33 million in 2025 and is expected to reach USD 16.96 million by 2030.
What is the growth rate of Brazil's mice model market?
Brazil's mice model market is growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2030.
What factors are driving growth in Brazil's mice model market?
Growth in Brazil is driven by increased government funding for life sciences, expanding research infrastructure, and rising demand from pharmaceutical and biotechnology companies for preclinical testing.
How does Brazil's market compare to other Latin American countries?
Brazil represents a significant portion of the Latin American mice model market, with steady growth supported by its robust pharmaceutical sector and research institutions.
What applications are driving mice model demand in Brazil?
Brazil's demand for mice models is primarily driven by drug discovery, preclinical testing, regulatory compliance requirements, and biomedical research in pharmaceutical and biotechnology sectors.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
- Rest Of Latin America Mice Model Market
- Ksa Mice Model Market
- Other GCC Countries Mice Model Market
- UAE Mice Model Market
- GCC Countries Mice Model Market
- Rest Of The Middle East Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report